Northern Trust’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Northern Trust’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-117,207	Closed	-$3.28M	–	4345
2019 Q3	$3.28M	Sell	117,207 -44,153	-27%	-$715K	﹤0.01%	2806
2019 Q2	$2.28M	Sell	161,360 -1,940	-1%	-$18.5K	﹤0.01%	3013
2019 Q1	$1.45M	Sell	163,300 -15,718	-9%	-$128K	﹤0.01%	3236
2018 Q4	$1.36M	Sell	179,018 -99	-0.1%	-$1.59K	﹤0.01%	3254
2018 Q3	$3.76M	Buy	179,117 +16,001	+10%	+$381K	﹤0.01%	2864
2018 Q2	$4.88M	Buy	163,116 +98,955	+154%	+$2.69M	﹤0.01%	2695
2018 Q1	$1.74M	Buy	64,161 +9,569	+18%	+$286K	﹤0.01%	3180
2017 Q4	$1.57M	Buy	54,592 +1,907	+4%	+$52.3K	﹤0.01%	3255
2017 Q3	$1.28M	Buy	+52,685	New	+$1.25M	﹤0.01%	3377

Northern Trust's DOVA Position: Q4 2019 in Review

Northern Trust sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 117,207 shares — an estimated $3.28M sold.

Northern Trust first reported a position in DOVA in Q3 2017 and held it in 9 quarters. The position peaked at $4.88M in Q2 2018. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Northern Trust reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Northern Trust sold 117,207 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $3.28M.
Northern Trust first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
Northern Trust's Dova Pharmaceuticals, Inc. Common Stock position peaked at $4.88M in Q2 2018.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.